Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.
Published Content
Total: 306
News
New Compound Restores Memory in Alzheimer’s Mouse Model
A new molecule developed by University of California Los Angeles (UCLA) researchers can restore lost cognitive functions in mice with symptoms of Alzheimer's disease, according to a new study published in PNAS.
News
Drug Candidate Shows Promise in Reversing MS Nerve Damage in Mouse Model
Researchers have developed a drug that shows promise in animal models of multiple sclerosis (MS). If successful in humans, the drug could help to replace the protective insulation around nerve cells lost because of the disease.
News
Popular Weight Loss Drug Shows Promise for Smoking Cessation
A new study has found that for people with type 2 diabetes, new use of semaglutide – which is also a popular weight loss drug – was linked with a lower risk of needing medical care for tobacco use disorder (TUD).
News
New Alzheimer’s Drug Rejected by European Medicines Agency Committee
A European Medicines Agency (EMA) committee has recommended the refusal of EU marketing authorization for Alzheimer’s drug lecanemab (Leqembi), which was only last year given the green light for approval by the US Food and Drug Administration (FDA).
News
New Shingles Vaccine May Cut Risk of Dementia
A new study suggests that the new, more effective recombinant shingles vaccine can also reduce the risk of dementia, similar to the vaccine’s discontinued predecessor.
News
Study Links Popular Weight Loss Drug to Risk of Rare Blinding Condition
People prescribed the diabetes/weight loss drug semaglutide (also known as Ozempic or Wegovy) have an increased risk of a potentially blinding eye condition, according to a new study from Mass Eye and Ear researchers.
News
Nearly Half of Cancer Cases Are Linked to Modifiable Risk Factors, Study Finds
A new study has found that 40% of cancer cases, and nearly 50% of all cancer deaths, are linked to “modifiable risk factors” such as cigarette smoking, excess body weight and alcohol consumption.
News
RSV Vaccine in Pregnancy Not Associated With Increased Preterm Birth Risk, Study Finds
A new study has found that a vaccine against respiratory syncytial virus (RSV) administered during pregnancy was not associated with increased risks of preterm birth or other poor outcomes.
Infographic
Antibodies in Screening
Download this infographic to learn more about therapeutic antibodies and their applications, the development of therapeutic antibodies and how high-throughput screening approaches and AI may enable antibody development.
News
Mediterranean Diet Linked to Lower Mortality for Cancer Survivors, Study Finds
Researchers have found that adhering to the Mediterranean diet – known for being rich in vegetables and whole grains and low in sugar and salt – can reduce the risk of mortality for cancer survivors.
Advertisement
